Fig. 2
Overexpression of TFAP2C correlates with advanced clinicopathological features and poor prognosis in CRC patients. a Representative images of TFAP2C expression in CRC tissues of different clinical stages. b The number of CRC tissues stratified by staining index of IHC. c Percentages and number of samples showed high or low TFAP2C expression in CRC tissues with different tumor volume. d Percentages and number of samples showed high or low TFAP2C expression in CRC tissues with different lymph node metastasis status. e Percentages and number of samples showed high or low TFAP2C expression in CRC tissues with different distant metastasis status. f Percentages and number of samples showed high or low TFAP2C expression in CRC tissues with different stage. g and h Kaplan-Meier overall survival and progression-free survival curves for CRC patients stratified by high and low expression of TFAP2C